Saturday, July 11, 2026

Drug profile · INN

t-cell

t-cell is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 229
News articles 0
Drug details — t-cell
Class
Route
Patents
20
Programs
229
Data quality
0.70

Quick answer

t-cell is an FDA-listed pharmaceutical active ingredient.

Key facts

INN t-cell

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. CADET-PAD Phase 3 · COLLEGIUM PHARMACEUTICAL · Ischemia of the lower limbs in the course of obstructive art
  2. CAIN457R12301 Phase 3 · Novartis India · Giant cell arteritis (GCA)
  3. CAIN457R1DE01 Phase 3 · Novartis India · Giant Cell Arteritis
  4. DCC-3014-03-001 Phase 3 · Anaxis Pharma · Tenosynovial Giant Cell Tumor
  5. E7777 9 mcg/kg Phase 3 · CITIUS ONCOLOGY · Persistent or Recurrent Cutaneous T-Cell Lymphoma
  6. M16-852 Phase 3 · AbbVie Deutschland GmbH · Giant Cell Arteritis
  7. Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell) Phase 3 · Chinese Academy of · HPV InfectioN
  8. SBI-0145-304 Phase 3 · Secura Bio · relapsed/refractory nodal T cell lymphoma with T follicular

Related patents

  1. US 12421302

    CAR-t cells and autoimmune diseases

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12421287

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 2025290040

    GAMMA DELTA T CELL COMPOSITIONS AND METHODS OF USE

    Expires Wed Sep 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12415843

    Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12404317

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12391742

    Anti-KRAS-G12D T cell receptors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12391741

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12391739

    Method for producing gamma delta T cells

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12384817

    Peptide having protective activity against cell damage caused by particulate matter, and uses for same

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12370256

    Activation of resident memory T cells for the treatment of cancer

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12358968

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 12344654

    Mage A4 T cell receptors

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 12344656

    Genetically engineered T cells having improved persistence in culture

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 12338459

    DNA-chimeric antigen receptor T cells for immunotherapy

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 12319740

    Methods for production of tissue resident memory-like T cells and use thereof

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 12312391

    Anti-mutated KRAS T cell receptors

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 12304900

    Islet cell manufacturing compositions and methods of use

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 12304940

    HLA class II-restricted t cell receptors against mutated RAS

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 12295362

    Formulations and processes for CAR T cell drug products

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 12295971

    Compositions and methods for enhancing adoptive T cell therapeutics

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is t-cell?

t-cell is an FDA-listed pharmaceutical active ingredient.